grik2

grik2

Overview

GRIK2 (Glutamate Ionotropic Receptor Kainate Type Subunit 2), also known as GluR6 or GluK2, is a member of the kainate family of ionotropic glutamate receptors. Kainate receptors represent a distinct class of glutamate-gated ion channels that play critical roles in synaptic transmission, neuronal excitability, and synaptic plasticity throughout the central nervous system. Unlike AMPA and NMDA receptors, kainate receptors exhibit unique pharmacological properties, slow kinetics, and are expressed both pre- and post-synaptically where they modulate neurotransmitter release and cellular signaling pathways. GRIK2 can form functional homomeric channels or heteromeric channels when co-assembled with other kainate receptor subunits, creating a diverse repertoire of receptor configurations with distinct pharmacological and physiological properties. Mutations in GRIK2 have been implicated in neurodevelopmental disorders including autism spectrum disorder and intellectual disability, while altered GRIK2 expression and function are observed in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/als).

grik2

Overview

GRIK2 (Glutamate Ionotropic Receptor Kainate Type Subunit 2), also known as GluR6 or GluK2, is a member of the kainate family of ionotropic glutamate receptors. Kainate receptors represent a distinct class of glutamate-gated ion channels that play critical roles in synaptic transmission, neuronal excitability, and synaptic plasticity throughout the central nervous system. Unlike AMPA and NMDA receptors, kainate receptors exhibit unique pharmacological properties, slow kinetics, and are expressed both pre- and post-synaptically where they modulate neurotransmitter release and cellular signaling pathways. GRIK2 can form functional homomeric channels or heteromeric channels when co-assembled with other kainate receptor subunits, creating a diverse repertoire of receptor configurations with distinct pharmacological and physiological properties. Mutations in GRIK2 have been implicated in neurodevelopmental disorders including autism spectrum disorder and intellectual disability, while altered GRIK2 expression and function are observed in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/als).

<div class="infobox infobox-protein"> [@borgesius2021]
<table> [@carpenter2023]
<tr><th colspan="2" style="background:#4a90d9;color:white;text-align:center">GRIK2 Protein</th></tr> [@contractor2022]
<tr><th>Full Name</th><td>Glutamate Receptor, Ionotropic, Kainate 2 (GluK2)</td></tr> [@fernandez2023]
<tr><th>UniProt ID</th><td>[Q16478](https://www.uniprot.org/uniprot/Q16478)</td></tr> [@gomez2024]
<tr><th>Gene Symbol</th><td>GRIK2</td></tr> [@huettner2023]
<tr><th>Chromosomal Location</th><td>6q16.3</td></tr> [@jiang2022]
<tr><th>Protein Length</th><td>906 amino acids</td></tr> [@kumar2023]
<tr><th>Molecular Weight</th><td>~100 kDa</td></tr> [@lerma2022]
<tr><th>Protein Class</th><td>Ionotropic glutamate receptor (kainate type)</td></tr> [@mendez2024]
<tr><th>Ion Conductance</th><td>Na+, K+, Ca2+ (low)</td></tr> [@noguchi2023]
<tr><th>Expression</th><td>Hippocampus, cortex, cerebellum, basal ganglia</td></tr> [@ortiz2022]
<tr><th>Associated Diseases</th><td>ASD, Epilepsy, Alzheimer's Disease, Parkinson's Disease, ALS</td></tr> [@paoletti2023]
</table>
</div>

Molecular Architecture and Biochemistry

Primary Structure

GRIK2 encodes a protein of 906 amino acids with a molecular weight of approximately 100 kDa. Like all ionotropic glutamate receptors, GluK2 adopts a modular architecture with distinct functional domains.

Domain Organization

Extracellular N-terminal Domain (NTD) (1-400 amino acids):

• Controls receptor assembly and trafficking
• Contributes to allosteric modulation
• Contains the kainate-binding domain
• Involved in subunit assembly and quality control

• Binds glutamate and selective agonists (kainic acid, ATPA)
• Undergoes closure upon agonist binding that drives channel opening
• Composed of two lobes (S1 and S2) connected by a hinge region
• Contains the binding pocket for glutamate and pharmacological agents

• Forms the ion channel pore with four transmembrane helices (M1-M4)
• The channel gate is located at M3
• M2 forms the pore loop determining ion selectivity
• Contains the Q/R editing site affecting calcium permeability

• Contains sites for phosphorylation (Ser, Thr, Tyr)
• Contains ubiquitination sites regulating degradation
• Contains PDZ-binding motifs for protein-protein interactions
• Critical for trafficking and signaling regulation

Subunit Assembly and Stoichiometry

Kainate receptors assemble as tetramers, and GRIK2 can form:

• Homomeric receptors: GluK2/GluK2/GluK2/GluK2
• Heteromeric receptors: Co-assembly with GluK1, GluK3, GluK4, or GluK5

• Single-channel conductance
• Pharmacology (agonist/antagonist sensitivity)
• Trafficking characteristics
• Localization patterns

RNA Editing

GRIK2 undergoes RNA editing at multiple sites [@borgesius2021]:

Q/R Site Editing (position 621):

• Converts glutamine (Q) to arginine (R) in the M2 pore helix
• Dramatically reduces calcium permeability
• Alters single-channel conductance
• Editing increases during development

• Located in the M1 helix
• Modulates channel properties

• Located in the extracellular domain
• Affects receptor assembly

Physiological Function

Synaptic Transmission

Presynaptic Modulation [@jiang2022]:

• Located on presynaptic terminals
• Regulate neurotransmitter release probability
• Act as autoreceptors sensing glutamate from same terminal
• Modulate both excitatory (glutamate) and inhibitory (GABA) release
• Produce short-term and long-term modifications of release

• Mediate slow excitatory postsynaptic potentials (EPSPs)
• Contribute to synaptic integration
• Can potentiate NMDA receptor responses in some contexts
• Located on dendritic shafts and spines

Neuronal Excitability

GluK2 contributes to neuronal excitability through:

• Depolarizing responses to glutamate
• Modulation of action potential threshold
• Regulation of firing patterns
• Control of network oscillations

Synaptic Plasticity

Kainate receptors are intimately involved in various forms of synaptic plasticity [@kumar2023]:

Long-term Potentiation (LTP):

• GluK2-containing receptors contribute to LTP induction
• In hippocampal CA3-CA1 synapses
• In cortical pyramidal neurons

• Activation of specific kainate receptor subtypes triggers LTD
• In cerebellar parallel fiber-Purkinje cell synapses

• Kainate receptors regulate the threshold for plasticity
• Through their modulatory effects on network excitability

Network Oscillations

Kainate receptors play important roles in brain oscillations:

• Theta oscillations (4-8 Hz): Modulation of hippocampal theta
• Gamma oscillations (30-100 Hz): Regulation of gamma coupling
• Sharp waves and ripples: Contribution to hippocampal replay

Expression Pattern

Regional Distribution

GRIK2 shows highest expression in:

Hippocampus:

• CA3 region (highest)
• Dentate gyrus
• CA1 (lower than CA3)
• Mossy fiber terminals

• Layer 2/3 pyramidal neurons
• Layer 5 pyramidal neurons
• Cortical interneurons

• Granule cells
• Molecular layer interneurons

• Striatum
• Substantia nigra pars reticulata

• Relay neurons
• Reticular nucleus

Cellular and Subcellular Localization

• Presynaptic terminals: Axon terminals of excitatory and inhibitory neurons
• Postsynaptic密度: Dendritic shafts and spines
• Axon initial segment: Regulation of neuronal output
• Somatic membrane: Some somatic expression

Developmental Regulation

• Embryonic: Low expression
• Postnatal: Increases dramatically
• Adult: Peak expression in early adulthood
• Aging: Gradual decline

Disease Associations

Autism Spectrum Disorder and Intellectual Disability

GRIK2 is one of the most consistently implicated glutamate receptor genes in neurodevelopmental disorders [@fernandez2023]:

Genetic Evidence:

• De novo missense variants cause intellectual disability with or without ASD
• Loss-of-function variants (truncating mutations, deletions) cause severe developmental delay
• Increased burden of rare coding variants in ASD cohorts
• Rare familial cases with inherited variants

• Disruption of kainate receptor function during critical developmental periods
• Effects on circuit formation and refinement
• Altered excitatory/inhibitory balance
• Impaired synaptic plasticity

Alzheimer's Disease

Alzheimer's disease is associated with multiple alterations in GRIK2 expression and function [@gomez2024]:

Expression Changes:

• Altered GRIK2 mRNA and protein levels in AD brains
• Changes in splice variant ratios
• Altered subcellular distribution

• Contributes to excitotoxicity through altered calcium handling
• Modulates amyloid-beta effects on synaptic function
• Alters tau-related synaptic dysfunction
• Changes in network excitability

• Kainate receptor modulators may reduce excitotoxicity
• Targeting GluK2 could restore synaptic function

Parkinson's Disease

Kainate receptors are implicated in [Parkinson's disease](/diseases/parkinsons-disease) and L-DOPA-induced dyskinesias [@taylor2023]:

Key Findings:

• Altered kainate receptor expression in PD models
• GRIK2 in striatal medium spiny neurons
• Modulation of dopaminergic signaling
• Role in levodopa-induced dyskinesias (LID)

• Altered striatal plasticity
• Dysregulated GABAergic transmission
• Changed corticostriatal signaling

Amyotrophic Lateral Sclerosis

Kainate receptors are involved in [ALS](/diseases/als) pathogenesis [@zhang2024]:

Key Findings:

• Altered kainate receptor function in ALS models
• Contribution to excitotoxicity
• Changes in motor neuron excitability

• Increased glutamate-induced toxicity
• Altered calcium buffering
• Dysregulated glutamate transport

Epilepsy

GRIK2 mutations cause various seizure disorders [@ortiz2022]:

Clinical Spectrum:

• Childhood absence epilepsy
• Myoclonic seizures
• Febrile seizures
• Temporal lobe epilepsy
• Epileptic encephalopathy

• Altered neuronal excitability
• Changes in network synchronization
• Dysregulated GABAergic inhibition
• Impaired synaptic plasticity

Huntington's Disease

• Dysregulated GRIK2 expression
• Contributes to excitotoxicity
• Altered corticostriatal transmission

Therapeutic Implications

Drug Development

Current Targets [@qian2024]:

| Drug/Compound | Target | Status | Application |
|--------------|--------|--------|-------------|
| LY466365 | GluK1 selective | Preclinical | Neuroprotection |
| UBP310 | Broad antagonist | Research | Epilepsy |
| LY382884 | GluK1 antagonist | Research | Anxiety |
| ATPA | GluK1 agonist | Research | Analgesic |

Challenges:

• Achieving subtype selectivity
• Blood-brain barrier penetration
• Managing side effect profile
• Understanding complex pharmacology

Potential Strategies

Agonists vs. Antagonists:

• Depends on disease context
• Antagonists for excitotoxicity
• Agonists for plasticity enhancement

• Greater selectivity potential
• Fewer side effects
• Current research focus

Interaction Partners

Core Complex Proteins

Ionotropic glutamate receptor complexes:

• Other kainate receptor subunits (GRIK1, GRIK3, GRIK4, GRIK5)
• AMPA receptor auxiliary subunits (stargazin family)
• NMDA receptor subunits

• PSD-95 family (SAP90 family)
• GRIP/GRIP1/GRIP2
• PICK1
• Shank family

Signaling Proteins

Kinases:

• PKA (phosphorylation of Ser/Thr)
• PKC (phorbol ester activation)
• CaMKII (activity-dependent phosphorylation)
• Src family kinases

• PP1
• PP2A
• Calcineurin

Regulatory Proteins

RNA binding proteins:
-调控RNA编辑
-调控可变剪接

Research Methods

Electrophysiology

• Patch-clamp recordings: Study channel properties
• Outside-out patches: Single-channel analysis
• Voltage-clamp: Current-voltage relationships
• Current-clamp: Firing pattern analysis

Molecular Biology

• CRISPR/Cas9: Generate knockout and knock-in models
• Site-directed mutagenesis: Structure-function studies
• RNAi: Knockdown studies

Imaging

• Live-cell imaging: Receptor trafficking
• Super-resolution microscopy: Synaptic localization
• FRAP: Membrane dynamics

Key Publications

See Also

• [GRIK2 Gene](/genes/grik2) - Gene page for GRIK2
• [GRIK1 Protein](/proteins/grik1-protein) - Related kainate receptor subunit
• [GRIK3 Protein](/proteins/grik3-protein) - Related kainate receptor subunit
• [Kainate Receptors](/entities/kainate-receptors) - Kainate receptor family
• [Glutamate Receptors](/entities/glutamate-receptors) - Ionotropic glutamate receptors
• [AMPA Receptors](/proteins/ampa-receptor) - Related glutamate receptor type
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity) - GluK2 role in plasticity
• [Excitotoxicity](/mechanisms/excitotoxicity) - Mechanism of neurodegeneration

References